Operator

Good afternoon, ladies and gentlemen, and welcome to the CV Sciences Q1 2026 Earnings Call. [Operator Instructions] Please note that this event is being recorded. I would now like to hand the conference over to Brendan Hawkins, Investor Relations. Please go ahead, sir.

Brendan Hawkins
Investor Relations

Thank you, and good afternoon, everyone. With us today with prepared remarks are CV Sciences' Chief Executive Officer, Joseph Dowling; and Joerg Grasser, Chief Financial Officer. After the prepared remarks, we will take questions from the analyst community. I'd like to remind you that during this call, management's prepared remarks may contain forward-looking statements.

These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those anticipated by CV Sciences at this time. When used in this call, the words anticipate, could, estimate, intend, expect, believe, potential, will, should, project, and similar expressions as they relate to CV Sciences, are as such a forward-looking statement.

Finally, please note that in today's call, management will refer to non-GAAP financial measures in which CV Sciences excludes certain expenses from its GAAP financial results. Please refer to CV Sciences' press release from earlier this afternoon for a full reconciliation of its non-GAAP performance measures to the most comparable GAAP financial measures.

As I just mentioned, this afternoon, the company issued a press release announcing its financial results. Participants on this call may not have already done so, may wish to look at the press release as the company provides a summary of the results on this call. The press release may be found at cvsciences.com.